Snowball logo
logo
3012

Guangdong Taienkang Pharmaceutical Co. Ltd

301263 SHE
¥20.58¥0.00  (0%)
Estimate
P/E
343
EPS
0.06
Beta
0.299
Growth
Revenue, YoY
2.63%
Net income, YoY
-9.39%
FCF, YoY
-168.52%
Forecast
P/E (FWD)
26.1
EPS (FWD)
0.79
Dividends
Dividend yield
0.2%
Annual payout
¥0.04
Next ex. div date
June 1, 27
Payout
326.83%
Div.rating
About the company
Ticker
301263
ISIN
CNE1000058X0
Country
China
Sector (GICS)
Healthcare
Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and sanitary materials, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs. The company was formerly known as Shantou Taikang Pharmaceutical Co., Ltd. and changed its name to Guangdong Taienkang Pharmaceutical Co., Ltd. in June 2006. Guangdong Taienkang Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Shantou, China.

Frequently asked questions

What sector does Guangdong Taienkang Pharmaceutical Co. Ltd (301263) operate in?

Guangdong Taienkang Pharmaceutical Co. Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Guangdong Taienkang Pharmaceutical Co. Ltd (301263) current stock price?

As of the latest data, Guangdong Taienkang Pharmaceutical Co. Ltd stock price is CN¥20.58, with a previous close of CN¥20.58.

What is Guangdong Taienkang Pharmaceutical Co. Ltd (301263) current market capitalization?

Guangdong Taienkang Pharmaceutical Co. Ltd market cap is approximately 10.51 billion.

What is Guangdong Taienkang Pharmaceutical Co. Ltd (301263) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.06, and the forward EPS is CN¥0.79.

What is Guangdong Taienkang Pharmaceutical Co. Ltd (301263) Price-to-Earnings (P/E) ratio?

Guangdong Taienkang Pharmaceutical Co. Ltd current P/E ratio is 343, with a forward P/E of 26.05.

Does Guangdong Taienkang Pharmaceutical Co. Ltd (301263) pay dividends?

Yes. Guangdong Taienkang Pharmaceutical Co. Ltd pays annual dividends with an annualized yield of 0.2% and an estimated annual payout of CN¥0.04 per share.

When is the next ex-dividend date for Guangdong Taienkang Pharmaceutical Co. Ltd (301263)?

The next ex-dividend date is scheduled for June 01, 2027.

What is Guangdong Taienkang Pharmaceutical Co. Ltd (301263) beta (volatility) score?

Guangdong Taienkang Pharmaceutical Co. Ltd has a beta of 0.299, indicating lower volatility than the overall market.